Calliditas Therapeutics AB ADR (CALT) Social Stream



Calliditas Therapeutics AB ADR (CALT): $17.79

-0.41 (-2.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About CALT

$CALT announced that the FDA has granted Fast Track Designation for its lead NOX inhibitor candidate setanaxib for the treatment of patients with the chronic orphan liver disease primary biliary cholangitis https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20210809045017CALT
briefingcom, published August 9, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.462 seconds.